Holen Sie sich die Stockscreener-App
14.49
5.51%
0.65
Schlusskurs vom Vortag:
$13.84
Offen:
$13.65
24-Stunden-Volumen:
326.25K
Relative Volume:
0.42
Marktkapitalisierung:
$1.53B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-150.70M
KGV:
-9.3484
EPS:
-1.55
Netto-Cashflow:
$-125.67M
1W Leistung:
+4.83%
1M Leistung:
+9.06%
6M Leistung:
-46.06%
1J Leistung:
-30.27%
1-Tages-Spanne:
$13.64
$14.74
1-Wochen-Bereich:
$13.53
$14.74
52-Wochen-Spanne:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Vergleichen Sie EWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.54 | 1.47B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
601.10 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.65 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.01 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Deutsche Bank AG Raises Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Volume Surge May Signal Institutional Interest in Edgewise Therapeutics Inc.July 2025 Catalysts & Verified Chart Pattern Signals - classian.co.kr
Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) CMO Sells 2,862 Shares of Stock - MarketBeat
Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) Insider Sells 1,907 Shares of Stock - MarketBeat
Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) CEO Sells 7,972 Shares of Stock - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) General Counsel John R. Moore Sells 2,098 Shares - MarketBeat
Insider Selling: Edgewise Therapeutics (NASDAQ:EWTX) CFO Sells 1,428 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - GlobeNewswire Inc.
What makes Edgewise Therapeutics Inc. stock price move sharplyTechnical Signal Trend Tracker Strategy - beatles.ru
Traders Consider Averaging Down in Edgewise Therapeutics Inc.Gold Moves & Technical Entry and Exit Alerts - sisa-n.com
Is Edgewise Therapeutics Inc. stock entering bullish territoryWeekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
What candlestick patterns are forming on Edgewise Therapeutics Inc.2025 Technical Overview & Reliable Volume Spike Alerts - Newser
Heatmap analysis for Edgewise Therapeutics Inc. and competitorsJuly 2025 Technicals & AI Driven Price Forecasts - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - cnhinews.com
Key resistance and support levels for Edgewise Therapeutics Inc.2025 Key Highlights & Technical Pattern Alert System - Newser
Real time scanner hits for Edgewise Therapeutics Inc. explainedJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
Quantitative breakdown of Edgewise Therapeutics Inc. recent move2025 Price Momentum & Fast Exit Strategy with Risk Control - Newser
Is Edgewise Therapeutics Inc. stock poised for growth2025 Short Interest & Accurate Technical Buy Alerts - Newser
How sentiment analysis helps forecast Edgewise Therapeutics Inc.Trade Exit Summary & Risk Controlled Stock Alerts - Newser
Intraday pattern recognizer results for Edgewise Therapeutics Inc.2025 Earnings Impact & Technical Entry and Exit Tips - Newser
Using AI based signals to follow Edgewise Therapeutics Inc.Weekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Applying Wyckoff theory to Edgewise Therapeutics Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
Wedbush Research Analysts Lower Earnings Estimates for EWTX - MarketBeat
Will Edgewise Therapeutics’ (EWTX) Rising Losses Reshape Its Long-Term Investment Strategy? - simplywall.st
Edgewise Therapeutics CBO sells shares worth $33,360 By Investing.com - Investing.com South Africa
Edgewise Therapeutics general counsel sells $28k in shares By Investing.com - Investing.com Canada
Edgewise Therapeutics CMO sells $38,329 in shares By Investing.com - Investing.com Canada
Edgewise Therapeutics CEO Kevin Koch sells $106k in shares By Investing.com - Investing.com South Africa
Edgewise Therapeutics CMO sells $38,329 in shares - Investing.com
Edgewise Therapeutics CFO sells $19k in shares By Investing.com - Investing.com Canada
Edgewise Therapeutics CSO sells $25,539 in EWTX stock By Investing.com - Investing.com India
Edgewise Therapeutics CBO sells shares worth $33,360 - Investing.com India
Edgewise Therapeutics CEO Kevin Koch sells $106k in shares - Investing.com India
Edgewise Therapeutics CFO sells $19k in shares - Investing.com India
Edgewise Therapeutics CSO sells $25,539 in EWTX stock - Investing.com
Edgewise Therapeutics general counsel sells $28k in shares - Investing.com
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Edgewise Therapeutics Inc-Aktie (EWTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MOORE JOHN R | General Counsel |
Aug 12 '25 |
Sale |
13.39 |
2,098 |
28,097 |
10,214 |
| Derakhshan Behrad | Chief Business Officer |
Aug 12 '25 |
Option Exercise |
0.00 |
5,781 |
0 |
26,136 |
| Derakhshan Behrad | Chief Business Officer |
Aug 12 '25 |
Sale |
13.39 |
2,491 |
33,360 |
23,645 |
| Carruthers R Michael | Chief Financial Officer |
Aug 12 '25 |
Option Exercise |
0.00 |
5,781 |
0 |
87,590 |
| Carruthers R Michael | Chief Financial Officer |
Aug 12 '25 |
Sale |
13.39 |
1,428 |
19,124 |
86,162 |
| Russell Alan J | Chief Scientific Officer |
Aug 12 '25 |
Option Exercise |
0.00 |
5,781 |
0 |
25,307 |
| Russell Alan J | Chief Scientific Officer |
Aug 12 '25 |
Sale |
13.39 |
1,907 |
25,539 |
23,400 |
| KOCH KEVIN | President and CEO |
Aug 12 '25 |
Option Exercise |
0.00 |
17,968 |
0 |
38,587 |
| KOCH KEVIN | President and CEO |
Aug 12 '25 |
Sale |
13.39 |
7,972 |
106,764 |
30,615 |
| Donovan Joanne M. | CMO |
Aug 12 '25 |
Option Exercise |
0.00 |
5,781 |
0 |
28,223 |
0.95%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):